Status:
COMPLETED
Sitagliptin in the Elderly
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Merck Frosst Canada Ltd.
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
65+ years
Phase:
PHASE2
Brief Summary
Diabetes is common in the elderly; by the age of 70, approximately 25% of the population will have diabetes. Unfortunately, currently available medications are often not as effective or not well toler...
Detailed Description
To date, no clinical trials have been conducted specifically in the elderly, but the data noted above from our laboratory would imply that inhibitors of this enzyme could be more effective in the elde...
Eligibility Criteria
Inclusion
- type 2 diabetes managed by diet or metformin only
- A1c \< 8.5%
Exclusion
- treated with insulin or oral agents other than metformin in the past 6 months
- evidence of diabetic complications including coronary artery disease, stroke, transient ischemic attacks, peripheral vascular disease, nephropathy, retinopathy, or neuropathy
- type 1 diabetes or a history suggestive of a secondary causes of diabetes
- A1c ≥ 8.5%
- participated in another clinical trial within the past 30 days
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00451113
Start Date
November 1 2006
End Date
November 1 2012
Last Update
January 18 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of British Columbia Gerontology & Diabetes Research Centre
Vancouver, British Columbia, Canada